Hyaluronic acid is among the world's most valuable biopolymers, with applications spanning from dermal fillers and wound healing to drug delivery and tissue engineering
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
The partnership aligns with the launch of Oracle Health’s next-generation electronic health record
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
The ALLEGORY study demonstrated statistically significant improvements in key measures, including British Isles Lupus Assessment Group-based Composite Lupus Assessment (BICLA) response
New Phase III data on gefurulimab highlight potential as a self-administered treatment option; real-world evidence reinforces clinical benefits of Ultomiris and Soliris
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks
Key secondary endpoints also demonstrated statistically significant and clinically meaningful benefits with Gazyva
Subscribe To Our Newsletter & Stay Updated
